Obesity Trial, Recruiting NCT05235945 Sponsor: University College, London Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05235945
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older.
  • People who are enrolled in the bariatric (weight loss) surgery program at UCLH, Homerton, or Whittington Hospitals, with a BMI over 30 kg/m².
  • People whose body weight has stayed within 5% of the same level over the past 3 months (meaning their weight has been fairly stable).
  • People who are willing and able to follow the trial's procedures and schedule.
  • People who are willing and able to sign a written consent form agreeing to take part.
  • People of any gender (male or female).

Who may not be able to join:

  • People who are currently pregnant or breastfeeding.
  • People who weigh more than 180 kg, due to limits on the equipment used in the trial.
  • People who are currently taking beta-blocker medications (a type of medication often used for heart conditions or blood pressure).
  • People who are already taking part in another clinical intervention trial at the same time.
  • People with serious ongoing health conditions — such as uncontrolled high blood pressure or unstable heart disease — that could put them at risk of a harmful response to exercise (confirm with trial site).
  • People who have had atrial fibrillation (an irregular heartbeat), unstable angina (severe chest pain), a heart attack or acute coronary syndrome, or significant heart failure (classified as New York Heart Association class III or IV) within the past 12 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Belinda Durey, UCL, UniSA and UNSW

Phone: +44 1752 600600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2023
Est. completion
1 June 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Fitness (VO2 in ml/kg/min)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov